Calmark Sweden AB (FRA:9C7) Current Accrued Expense : €0.00 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Calmark Sweden AB Current Accrued Expense?

Calmark Sweden AB's Current Accrued Expense for the quarter that ended in Sep. 2023 was €0.00 Mil.

Calmark Sweden AB Current Accrued Expense Historical Data

The historical data trend for Calmark Sweden AB's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calmark Sweden AB Current Accrued Expense Chart

Calmark Sweden AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Current Accrued Expense

Calmark Sweden AB Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Current Accrued Expense	Get a 7-Day Free Trial									-	-	-	-	-

Calmark Sweden AB Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Calmark Sweden AB Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Calmark Sweden AB's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Calmark Sweden AB (FRA:9C7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Calmark Sweden AB (FRA:9C7) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CALMA B:Sweden

Address

Sommargatan 101A, Karlstad Innovation Park, lokal Manegen, Karlstad, SWE, SE-656 37

Website

https://www.calmark.se

Calmark Sweden AB provides tests for a newborn. The company's product Calmark's developed a point-of-care (POC) diagnostic instrument which makes it easier and faster to measure biomarkers for disease states in newborns. The company's PNA instrument consists of a reader and a disposable product that is placed in the reader when measured.

Calmark Sweden AB (FRA:9C7) Headlines

No Headlines